Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01941927
Title Trametinib With GSK2141795 in BRAF Wild-type Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Adil Daud
Indications

melanoma

Therapies

Trametinib + Uprosertib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST